Literature DB >> 18312221

Classification of breast cancer versus normal samples from mass spectrometry profiles using linear discriminant analysis of important features selected by random forest.

Somnath Datta1.   

Abstract

We present our approach to classifying the processed proteomic data that were made available to the participants of the classification competition. Although classification of the spectra was the goal of the competition we feel that proteomic applications to cancer biomarker studies make certain additional demands. For example, one such requirement should be identification of certain features which collectively could differentiate the two groups of samples. Also ideally, the size of the feature set should be small. To that end we propose a linear discriminant classifier based on nine m/z intensity values. Construction and performance of this classifier are discussed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18312221     DOI: 10.2202/1544-6115.1345

Source DB:  PubMed          Journal:  Stat Appl Genet Mol Biol        ISSN: 1544-6115


  9 in total

1.  Gene Selection with Sequential Classification and Regression Tree Algorithm.

Authors:  Caleb D Bastian; Grzegorz A Rempala
Journal:  Biostat Bioinforma Biomath       Date:  2011-08-01

2.  Breast Cancer Proteomics - Differences in Protein Expression between Estrogen Receptor-Positive and -Negative Tumors Identified by Tandem Mass Tag Technology.

Authors:  Eugen Ruckhäberle; Thomas Karn; Lars Hanker; Josef Schwarz; Peter Schulz-Knappe; Karsten Kuhn; Gitte Böhm; Stefan Selzer; Neukum Erhard; Knut Engels; Uwe Holtrich; Manfred Kaufmann; Achim Rody
Journal:  Breast Care (Basel)       Date:  2010-02-16       Impact factor: 2.860

3.  An adaptive optimal ensemble classifier via bagging and rank aggregation with applications to high dimensional data.

Authors:  Susmita Datta; Vasyl Pihur; Somnath Datta
Journal:  BMC Bioinformatics       Date:  2010-08-18       Impact factor: 3.169

4.  Boosting for high-dimensional two-class prediction.

Authors:  Rok Blagus; Lara Lusa
Journal:  BMC Bioinformatics       Date:  2015-09-21       Impact factor: 3.169

5.  Isoform-level gene signature improves prognostic stratification and accurately classifies glioblastoma subtypes.

Authors:  Sharmistha Pal; Yingtao Bi; Luke Macyszyn; Louise C Showe; Donald M O'Rourke; Ramana V Davuluri
Journal:  Nucleic Acids Res       Date:  2014-02-06       Impact factor: 16.971

6.  Implementation of Machine Learning Mechanism for Recognising Prostate Cancer through Photoacoustic Signal.

Authors:  G Ramkumar; P Bhuvaneswari; R Radhika; S Saranya; S Vijayalakshmi; M Karpagam; Florin Wilfred
Journal:  Contrast Media Mol Imaging       Date:  2022-09-20       Impact factor: 3.009

7.  A new pipeline for structural characterization and classification of RNA-Seq microbiome data.

Authors:  Sebastian Racedo; Ivan Portnoy; Jorge I Vélez; Homero San-Juan-Vergara; Marco Sanjuan; Eduardo Zurek
Journal:  BioData Min       Date:  2021-07-09       Impact factor: 2.522

8.  The Application of Classification and Regression Trees for the Triage of Women for Referral to Colposcopy and the Estimation of Risk for Cervical Intraepithelial Neoplasia: A Study Based on 1625 Cases with Incomplete Data from Molecular Tests.

Authors:  Abraham Pouliakis; Efrossyni Karakitsou; Charalampos Chrelias; Asimakis Pappas; Ioannis Panayiotides; George Valasoulis; Maria Kyrgiou; Evangelos Paraskevaidis; Petros Karakitsos
Journal:  Biomed Res Int       Date:  2015-08-03       Impact factor: 3.411

9.  Pathway-centric integrative analysis identifies RRM2 as a prognostic marker in breast cancer associated with poor survival and tamoxifen resistance.

Authors:  Nagireddy Putluri; Suman Maity; Ramakrishna Kommagani; Ramakrishna Kommangani; Chad J Creighton; Vasanta Putluri; Fengju Chen; Sarmishta Nanda; Salil Kumar Bhowmik; Atsushi Terunuma; Tiffany Dorsey; Agostina Nardone; Xiaoyong Fu; Chad Shaw; Tapasree Roy Sarkar; Rachel Schiff; John P Lydon; Bert W O'Malley; Stefan Ambs; Gokul M Das; George Michailidis; Arun Sreekumar
Journal:  Neoplasia       Date:  2014-05       Impact factor: 5.715

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.